Epigenetic regulation of cell fate choice and differentiation
Posted by Anna Philpott, on 12 July 2019
Closing Date: 15 March 2021
A post-doctoral position is available to study transcriptional regulation of lineage fidelity during fate specification and differentiation of ES cells. This project focuses on uncovering epigenetic and co-factor-dependent mechanisms underlying these processes.
The Philpott lab has broad interests in understanding the fundamental mechanisms that determine cell fate choice and differentiation during embryonic development and in cancers, as well as how these processes are co-ordinated with cell cycle progression.
Within the laboratory, we use several experimental systems including mammalian embryonic stem cells, cancer cell culture, organoid systems as well as embryos of the frog Xenopus. We use many techniques including genome-wide analysis of gene expression in single and multiple cells, chromatin binding and accessibility studies and crispr genome editing, alongside diverse biochemical approaches.
The successful candidate will have a PhD, considerable experience in stem cell biology, epigenetics, molecular biology, developmental biology, or a similar field, and a proven track record in scientific publication. Prior experience in mammalian cell culture is essential. Experience of epigenetics and/or transcriptional regulation are essential, while experience of genome-wide transcriptional analysis, and in particular analysis at the single cell level, would also be an advantage. Applicants must display an ability to undertake project management, work within a multi-disciplinary team environment, have excellent presentation and communication skills and the ability to contribute to an environment supporting researchers at all stages of their careers.
The Wellcome – MRC Cambridge Stem Cell Institute (CSCI) is a world-leading centre for stem cell research with the mission to transform human health through a deep understanding of stem cell biology. https://www.stemcells.cam.ac.uk/
CSCI is due to move to the brand new, state of the art Jeffrey Cheah Biomedical Centre building on the Cambridge Biomedical Campus in summer 2019.
Fixed Term: The funds for this post are available for 3 years in the first instance. Deadline: July 28th, 2019.
Application and further particulars is online via this weblink: https://www.stemcells.cam.ac.uk/Join_Us/vacancies
Informal enquiries should be directed to Prof. Anna Philpott, ap113@cam.ac.uk. recent line manager.
The University values diversity and is committed to equality of opportunity. The University has a responsibility to ensure that all employees are eligible to live and work in the UK.
(No Ratings Yet)
Loading...